Home
>
US Stocks
>
ChemoCentryx Inc
ChemoCentryx Inc
CCXI

ChemoCentryx Inc

$34.51123.22%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
36.69
Today Low/High
34.46 / 36.69
52 Week Low/High
$9.53 / $70.29
Market Cap
$956.28M

Company Details

ChemoCentryx is a biopharmaceutical company developing new medications for inflammatory and autoimmune diseases and cancer. ChemoCentryx targets the chemokine and chemoattractant systems to discover, develop and commercialize orally-administered therapies. ChemoCentryx's lead drug candidate, avacopan (CCX168), successfully completed a pivotal Phase III trial in ANCA-associated vasculitis and a New Drug Application is under review by the U.S. Food and Drug Administration. Avacopan is also in late stage clinical development for the treatment of severe Hidradenitis Suppurativa and C3 glomerulopathy (C3G). ChemoCentryx also has early stage drug candidates that target chemoattractant receptors in other inflammatory and autoimmune diseases and in cancer.
Organisation
ChemoCentryx Inc
Headquaters
Mountain View, California, US
Employees
133
Industry
Health Technology
CEO
Thomas Schall

Discover more

Frequently Asked Questions

What is ChemoCentryx Inc share price today

Can Indians buy ChemoCentryx Inc shares?

How can I buy ChemoCentryx Inc shares from India?

Can Fractional shares of ChemoCentryx Inc be purchased?

What are the documents required to start investing in ChemoCentryx Inc stocks?

We are a SEBI registered investement advisor